MENU
CLOSE
Home
News
2016 Announcements
Page 3
2016 Announcements
Filters:
Category
Latest
2016 Announcements
2017 Announcements
2018 Announcements
2019 Announcements
2020 Announcements
2021 Announcements
2022 Announcements
2023 Announcements
2024 Announcements
Clinical
Corporate
Financial
News
Newsletter
Pages
Presentation
Recruitment
Regulatory
Stories
Appendix 4C – Q4 FY16
2016 Announcements
28.07.2016
FDA accepts SCENESSE® clinical data package for NDA submission
2016 Announcements
17.07.2016
FDA awards SCENESSE® Fast Track designation for treatment of EPP
2016 Announcements
05.07.2016
CLINUVEL’s SCENESSE® launched in Europe
2016 Announcements
20.06.2016
CLINUVEL added to Nasdaq International Designation
2016 Announcements
31.05.2016
SCENESSE® treatment in Europe
2016 Announcements
17.05.2016
Appendix 4C – Q3 FY16
2016 Announcements
29.04.2016
Form 604
2016 Announcements
11.04.2016
CLINUVEL Newsletter – April 2016
2016 Announcements
04.04.2016
NICE Highly Specialised Technology workshop reviews SCENESSE®
2016 Announcements
23.03.2016
s.708A Notice
2016 Announcements
18.03.2016
Appendix 3B
2016 Announcements
18.03.2016
Form 604
2016 Announcements
18.03.2016
.
‹
1
2
3
4
›
About
About CLINUVEL
People
Corporate Governance
Photomedicine Foundation
Annual Reports
Pharmaceuticals
About Pharmaceuticals
The Science
Disease Entities
Products
PhotoCosmetics
About PhotoCosmetics
Polychromatic Photoprotection
DNA Repair
Melanogenesis
Investors
Investors Information
ASX Announcements
Analyst Coverage
Media Coverage
Company Snapshot
Financial Summary
Shareholder Information
Investor Enquiry
News
Contact
Store
Go To Top